TABLE 5.

Treatment response and outcome of 146 dogs with immune‐mediated hematologic disorder (IMHD), in which the treatment included mTPE (n = 17) or was limited to immunosuppressive treatment (controls, n = 129)

IMHA (n = 94)	mTPE (n = 12)	Controls (n = 82)	P
No response	2 (17%)	29 (35%)	.33 (responders vs nonresponders)
Partial response	5 (42%)	42 (51%)
Complete response	5 (42%)	11 (13%)
Survivors	10 (83%)	57 (70%)	.5 (survivors vs nonsurvivors)
Nonsurvivors [death/euthanasia]	2 (17%) [1/1]	25 (30%) [3/22]

IMT (n = 76)	mTPE (n = 10)	Controls (n = 66)
No response	2 (20%)	20 (30%)	.71 (responders vs nonresponders)
Partial response	0 (0%)	7 (11%)
Complete response	8 (80%)	39 (59%)
Survivors	8 (80%)	41 (62%)	.48 (survivors vs nonsurvivors)
Nonsurvivors [death/euthanasia]	2 (20%) [1/1]	25 (38%) [6/19]